Kedrion Biopharma
Duccio Manetti, PhD, currently serves as the Group Chief Communications & Government Affairs Officer at Kedrion Biopharma, overseeing communication strategies and government affairs since July 2023. With a robust academic background, Duccio is also a guest lecturer on Marketing and Corporate Communications at Quadriga University and a global mentor for MENTEE, a nonprofit focused on mentorship for marginalized groups. Previous roles include Global Director of Communication at Bracco, External Communication Director at Tetra Pak, and various positions at Baker Hughes and GE, where Duccio led numerous marketing communications initiatives and digital strategies. Duccio holds a PhD in Philosophy and Cognitive Sciences, along with multiple degrees in Philosophy and Communication from the University of Florence.
This person is not in any teams
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.